AMPK

Signaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S2697 A-769662 <1 mg/mL 72 mg/mL <1 mg/mL
S1802 AICAR (Acadesine) <1 mg/mL 51 mg/mL <1 mg/mL
S7306 Dorsomorphin (Compound C) 2HCl 94 mg/mL <1 mg/mL <1 mg/mL
S2542 Phenformin HCl 48 mg/mL 48 mg/mL 12 mg/mL
S7317 WZ4003 <1 mg/mL 7 mg/mL <1 mg/mL
S7318 HTH-01-015 <1 mg/mL 58 mg/mL 30 mg/mL
S7898 GSK621 <1 mg/mL 97 mg/mL <1 mg/mL
S7953 ETC-1002 <1 mg/mL 68 mg/mL <1 mg/mL
S7840 Dorsomorphin (Compound C) <1 mg/mL 3 mg/mL 2 mg/mL
Catalog No. Information Product Use Citations Product Validations
S2697

A-769662

A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM in cell-free assays, little effect on GPPase/FBPase activity.

S1802

AICAR (Acadesine)

AICAR (Acadesine), an AMPK activator, results in accumulation of ZMP, which mimics the stimulating effect of AMP on AMPK and AMPK kinase. Phase 3.

S7306

Dorsomorphin (Compound C) 2HCl

Dorsomorphin 2HCl is a potent, reversible, selective AMPK inhibitor with Ki of 109 nM in cell-free assays, exhibiting no significant inhibition of several structurally related kinases including ZAPK, SYK, PKCθ, PKA, and JAK3. Also inhibits type Ⅰ BMP receptor activity.

S2542

Phenformin HCl

Phenformin HCl is a hydrochloride salt of phenformin that is an anti-diabetic drug from the biguanide class. It activates AMPK, increasing activity and phosphorylation.

S7317

WZ4003

WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2 in cell-base assays, respectively, without significant inhibition on 139 other kinases.

S7318

HTH-01-015

HTH-01-015 is a potent and selective NUAK1 inhibitor with IC50 of 100 nM, >100-fold selectivity over NUAK2.

S7898

GSK621

GSK621 is a specific and potent AMPK activator.

S7953

ETC-1002

ETC-1002,also known as Bempedoic acid, is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies.ETC-1002 is an activator of hepatic AMP-activated protein kinase (AMPK). It has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).

S7840

Dorsomorphin (Compound C)

Dorsomorphin is a potent, reversible, selective AMPK inhibitor with Ki of 109 nM in cell-free assays, exhibiting no significant inhibition of several structurally related kinases including ZAPK, SYK, PKCθ, PKA, and JAK3. Also inhibits type I BMP receptor activity.

Catalog No. Information Product Use Citations Product Validations
A5008New

AMPK alpha 1 Rabbit Recombinant mAb

A5025New

AMPK gamma 1 Rabbit Recombinant mAb

Tags: AMPK inhibition | AMPK activation | AMPK phosphorylation | AMPK activity | AMP-activated protein kinase pathway | AMPK activity assay | AMPK activators review | AMPK activity assay | AMPK inhibitor cancer | AMPK agonists | AMPK antagonist | AMPK inhibitor review